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Abstract 
Bovine ephemeral fever (or 3-day sickness) is an acute febrile illness of cattle and water buffaloes. Caused by an 
arthropod-borne rhabdovirus, bovine ephemeral fever virus (BEFV), the disease occurs seasonally over a vast expanse 
of the globe encompassing much of Africa, the Middle East, Asia and Australia. Although mortality rates are typically 
low, infection prevalence and morbidity rates during outbreaks are often very high, causing serious economic impacts 
through loss of milk production, poor cattle condition at sale and loss of traction power at harvest. There are also sig-
nificant impacts on trade to regions in which the disease does not occur, including the Americas and most of Europe. 
In recent years, unusually severe outbreaks of bovine ephemeral fever have been reported from several regions in Asia 
and the Middle East, with mortality rates through disease or culling in excess of 10–20%. There are also concerns that, 
like other vector-borne diseases of livestock, the geographic distribution of bovine ephemeral fever could expand 
into regions that have historically been free of the disease. Here, we review current knowledge of the virus, including 
its molecular and antigenic structure, and the epidemiology of the disease across its entire geographic range. We also 
discuss the effectiveness of vaccination and other strategies to prevent or control infection.
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1 Introduction
Bovine ephemeral fever virus (BEFV) an arthropod‑
borne rhabdovirus which is classified as the type species 
of the genus Ephemerovirus. It causes an acute febrile ill‑
ness of cattle and water buffalo known as bovine ephem‑
eral fever (BEF) or various other local names such as 
3‑day sickness, bovine enzootic fever, bovine influenza or 
stiffseitke. It occurs over a vast expanse of the globe from 
the southern tip of Africa to the Nile River Delta, across 
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the Middle East through South and South‑East Asia, into 
northern and eastern Australia, and throughout most of 
China, extending into Taiwan, the Korean Peninsula and 
southern Japan (Figure  1). BEFV does not occur in the 
islands of the Pacific, Europe (other than in the western 
regions of Turkey) or in the Americas where, for quar‑
antine purposes, it is considered as an important exotic 
pathogen. Infection may be clinically unapparent or 
result in mild to severe clinical signs including a bi‑phasic 
fever, salivation, ocular and nasal discharge, recumbency, 
muscle stiffness, lameness and anorexia. Sternal and lat‑
eral recumbency in cattle with clinical BEF are shown 
in Additional file 1. Usually, the disease is characterised 
by rapid onset and rapid recovery, lasting only 1–3 days, 
but there are reports of prolonged paralysis and ataxia 
in some animals following the acute phase of infection. 
The most severe cases can result in mortality which may 
be due to exposure, starvation or pneumonia, but little is 
currently known about the direct cause of death. Morbid‑
ity rates can be very high (approaching 100%) and mor‑
tality rates are typically low (<1%). However, in recent 
years there have been reports from several countries of 
alarmingly high case‑fatality rates, sometimes exceeding 
20% [1–3]. The economic impacts of BEF can be con‑
siderable and are due primarily to cessation of lactation 
in dairy cattle, loss of condition in beef cattle and the 
immobilisation of water buffalo used for draught power 
[4–7]. A recent study has estimated an average net loss 
of 175.9  kg milk per cow affected by BEF [7]. BEF also 
impacts on trade in live cattle from infected zones and 
there is some evidence that the risks of inter‑continen‑
tal spread of BEFV through animal transport or vector 
translocation may be increasing [8].
2  Molecular and antigenic characteristics of BEFV
2.1  Molecular structure
BEFV displays typical rhabdovirus bullet‑shaped mor‑
phology (Figure 2), although virions (~185 nm × ~75 nm) 
appear to be more tapered at one end than the rounded 
forms that are observed for vesicular stomatitis virus 
(VSV) or rabies virus (RABV) [9]. Helical nucleocap‑
sids comprise the negative‑sense, single‑stranded RNA 
genome tightly associated with the 52 kDa nucleoprotein 
(N) which, together with the 43 kDa phosphoprotein (P) 
and the large multi‑functional enzyme (L) form a ribo‑
nucleoprotein complex [10]. Nucleocapsids are encased 
in the 29  kDa matrix protein (M) and a lipid envelope 
through which an 81  kDa class 1 transmembrane gly‑
coprotein (G) protrudes to form surface projections [9]. 
Defective‑interfering particles with truncated cone‑
shaped morphology are commonly present in purified 
virus preparations (Figure 2).
The 14.9  kb BEFV genome is much larger and more 
complex than those of VSV or RABV, possibly explain‑
ing the subtle difference in virion morphology (Figure 2). 
In addition to the five canonical rhabdovirus structural 
Figure 1 Countries in which BEF is known to occur or from which the disease has been reported historically (shown in blue). The 
extent of BEFV distribution is not necessarily country-wide (as shown) and may include neighbouring countries from which there are no known 
formal reports of disease (not shown). The distribution may also vary seasonally and from year to year.
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protein genes, the BEFV genome features a ~3.4  kb 
region between the G and L genes containing multiple 
additional open reading frames (ORFs) [11]. Thus, the 
genome contains a total of 10 long open reading frames 
(ORFs) arranged in the order 3′‑N‑P‑M‑G‑[GNS‑α1‑α2‑
β‑γ]‑L‑5′ (in negative sense). The GNS gene encodes a 
90 kDa class 1 transmembrane glycoprotein that is struc‑
turally related to the G protein and appears to have been 
generated by gene duplication [12]. The GNS protein is 
expressed in infected cells but is not incorporated into 
virions and, unlike the G protein, does not appear to be 
fusogenic at low pH [13, 14]. Its function is presently 
unknown. The α1 gene encodes a 10.5  kDa transmem‑
brane protein that is expressed in infected cells and has 
the structural and functional properties of a viroporin 
[15]. BEFV α1 protein localises to the Golgi complex 
and has been shown to bind importin β1 and importin 
7, suggesting that it may also have a role in modulat‑
ing nuclear trafficking pathways [15]. The functions of 
proteins encoded in the α2, β and γ ORFs are presently 
unknown. However, it has been observed that expression 
of the β and γ ORFs is selectively suppressed by muta‑
tion during adaptation to cell culture, suggesting that 
their role is associated with infection in vivo (P.J. Walker, 
unpublished data). Short alternative ORFs also occur in 
different frames within the P and α2 ORFs but it is not 
known if they are expressed as functional proteins.
2.2  Antigenic structure
The BEFV G protein is the target of virus‑neutralising 
antibodies [16, 17]. The G protein shares structural 
homology with the G proteins of other animal rhabdovi‑
ruses [18, 19], including the VSV G protein for which the 
crystal structure has been resolved. Three major neutrali‑
sation sites (G1–G3) have been defined by using BEFV G 
protein‑specific monoclonal antibodies (MAbs) in com‑
petition ELISAs [17]. The sites have been confirmed by 
selection of neutralisation escape mutants [20] and physi‑
cally mapped to the G protein structure by sequence 
analysis of the mutants [18, 21]. A fourth site (G4) has 
also been defined by a MAb‑selected neutralisation 
escape mutant but it has not yet been mapped physically 
[20]. G1 is a linear neutralisation site (Y487‑K503) that is 
located at the end of the trimerisation domain (DII) just 
before the C‑terminal stalk of the G protein [18, 21]. It 
comprises two minimal B cell epitopes that map to each 
end of the site [21]. G2 is a conformational site which is 
located at the base of the fusion domain (DIV) adjacent 
Figure 2 Structure and morphology of BEFV. A Structural organization of the 14.9 kb BEFV genome shown as arranged in negative sense. 
Structural protein genes (N, P, M, G and L) are shown in black and the various accessory genes are coloured. B Transmission electron micrograph 
showing BEFV virions and defective-interfering (DI) particles. Scale bar 100 nm. Reproduced from Walker [7] with permission from Springer-Verlag. C 
Structural model of a monomeric subunit of the BEFV G protein derived by homology modelling using the pre-fusion form of the VSV G protein as 
a template. The model illustrates the three major neutralization sites (G1, G2 and G3a/b) and amino acid residues shown to be under positive selec-
tion in Australia [18]. Adapted with permission from the American Society for Microbiology.
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to a disulphide bridge (C172–C182) that forms a loop con‑
taining a predicted N‑glycosylation site. G3 is the major 
conformational site in the BEFV G protein, occupying 
most of the base of the pleckstrin homology (PH) domain 
(DIII). It comprises amino acids from three linear regions 
of the G protein that are aligned by the fold. It includes 
two sub‑sites (G3a and G3b) defined by either partial or 
complete inhibition of MAb binding in competition ELI‑
SAs [18, 21]. Each of these antigenic sites is predicted to 
be exposed at the surface of the G protein (Figure 2). Both 
G2 and G3 are predicted to be available to neutralising 
antibodies in the pre‑fusion form of the G protein [18]. 
Site G2 is on the lateral face of the trimer. Site G3 is at the 
distal end of the spike and corresponds to the major con‑
formational sites of VSV and RABV which are thought to 
be involved in receptor‑binding. Site G1 is predicted to 
face the viral membrane in both the pre‑fusion and post‑
fusion forms of the trimer and may be accessible to anti‑
bodies only during a transitional monomeric phase [18].
The BEFV N protein is also immunogenic in cattle and 
in mice. It does not induce virus‑neutralising antibodies 
or a protective response [22, 23] but it does induce a T 
cell proliferative response in cattle [22]. All 12 available 
BEFV N protein MAbs are non‑neutralising and have 
been mapped to non‑conformational sites in the C‑ter‑
minal half of the protein. Two of these MAbs have been 
shown to cross‑react in immunoblots with the rabies 
virus N protein [23] and this may explain weak cross‑
reactions detected in indirect immunofluorescence tests 
between certain lyssaviruses and ephemeroviruses [24]. 
Monoclonal antibodies have also been generated to 
the BEFV M protein. They are all non‑neutralising and 
appear to bind to non‑conformational sites but have not 
been physically mapped to the protein [17].
2.3  Antigenic variation
BEFV is considered to exist as a single serotype world‑
wide. Various neutralisation tests conducted using iso‑
lates from Australia, China, Japan, Kenya, Nigeria and 
South Africa have demonstrated strong antigenic cross‑
reactions [25–29]. There is also anecdotal evidence that 
vaccines developed in several countries using BEFV 
strains isolated more than 40 years ago remain effective 
against currently circulating strains and that vaccines 
developed against a strain of the virus from one region 
are effective against viruses currently circulating in other 
regions of the world. Nevertheless, homologous neutrali‑
sation titres are typically higher than heterologous titres 
amongst viruses isolated at different times or from differ‑
ent geographic regions [1, 27, 28].
Variations have also been detected in the major neu‑
tralisation sites of the G protein. A study of 66 Austral‑
ian BEFV isolates collected between 1956 and 1992 has 
indicated that, whilst all isolates were neutralised by 
MAbs representing antigenic sites G1, G2 and G4, vari‑
ations have occurred in some epitopes within the major 
conformational site G3, allowing the identification of 
four antigenic sub‑types [18, 20]. Isolates assigned to 
subtype I were neutralised by MAbs (generated against 
the 1968 isolate BB7721) representing all four antigenic 
sites; subtype II isolates lack an epitope in site G3a; sub‑
type III isolates lack an epitope in site G3b; and subtype 
IV isolates lack both the G2a and G3b epitopes. Interest‑
ingly, whilst variations in the site G3b epitope showed 
no temporal or geographic association, the G3a epitope 
was found to be present in all viruses isolated prior to 
1973–74 and absent from all viruses isolated since that 
time [18]. Sequence analysis of the isolates indicated that 
variations in site G3a were associated with a conservative 
substitution at amino acid 218 (R218K) and that varia‑
tions in the site G3b epitope were primarily associated 
with various substitutions or deletions at amino acid 215 
(Figure 2). Variations were also observed in other amino 
acids in regions that had been mapped previously to sites 
G1, G2 or G3 but they did not affect the neutralisation 
phenotypes of epitopes targeted by the MAbs used in the 
study [18]. Analyses of the G protein sequences of BEFV 
isolates from Japan and Taiwan, mainland China and the 
Middle East have also revealed variations in amino acids 
in regions that correspond to antigenic sites G1, G2 and 
G3 [3, 30–32]. However, the MAb‑neutralisation pheno‑
types of these isolates have not been determined.
3  Ecology of BEF infection
3.1  Vertebrate host range
Clinical BEF has been reported only in cattle and water 
buffalo (Bubalus bubalis). Although cattle are considered 
to be more susceptible to disease [33, 34], mild clinical 
signs have been reproduced experimentally in water buf‑
falo [35] and severe disease has been reported in the field 
[36]. There is also evidence of infection and clinical BEF 
in yak (Bos grunniens) in China and India [37, 38]. Sero‑
logical studies have detected BEFV antibodies in a wide 
range of wild ungulates. In surveys conducted in Kenya, 
Tanzania, Zimbabwe and South Africa, BEFV‑neutralising 
antibodies have been detected in African buffalo (Syn-
cerus caffer), waterbuck (Kobus ellipsiprymnus) wildebeest 
(Connochaetes taurinus, Connochaetes gnou), hartebeest 
(Alcelaphus buselaphus), topi (Damaliscus korrigum), 
tsessebe (Damaliscus lunatus), blesbok (Damaliscus dor-
cas phillipsi), springbok (Antidorcus marsupialis), impala 
(Aepycerus melampus), sable antelope (Hippotragus niger), 
eland (Taurotargus oryx), kudu (Tragelaphus strepsiceros), 
bushbuck (Tragelaphus scriptus) and giraffe (Giraffa 
camelopardalis) [39–42]. In other African, countries expo‑
sure to BEFV infection has been reported in lechwe (Kobus 
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leche), elephant (Loxodonta africana), warthog (Phacoch-
oerus aethiopicus), oryx (Oryx beisa), hippopotamus (Hip-
popotamus amphibius) and gazelle (Gazella granti) [41]. 
In some cases, the prevalence of BEFV antibodies in Afri‑
can wildlife was quite high (over 60% of animals tested), 
suggesting they may serve as natural reservoirs of infec‑
tion in which the virus cycles during inter‑epizootic peri‑
ods [39, 42]. BEFV‑neutralising antibodies have also been 
detected in Persian fallow deer (Dama d. mesopotamica) 
and gazelle (Gazella g. gazella) in Israel [43], pigs (Sus 
scrofa) in Korea [44], and red deer (Cervus elaphus), Rusa 
deer (C. timorensis) and Chital deer (Axis axis) in Australia 
[5, 45, 46]. There is also evidence of infection in camels 
(Camelus dromedaries) in Egypt and Somalia [47] and an 
ephemeral fever‑like illness known locally as “Lahaw‑Gaal” 
has been reported to affect camels in Somalia and north‑
eastern Kenya [48]. Generally, the low prevalence of BEFV 
antibody in these species and their quite small populations 
relative to cattle and water buffalo suggests that they may 
have little importance in the overall ecology of infection 
outside of Africa.
Sheep have also been infected experimentally with 
BEFV but did not develop clinical signs other than 
pyrexia and attempts to isolate the virus failed [49, 50]. 
However, some sheep developed BEFV‑neutralising anti‑
bodies and mild haematological changes, and clinical dis‑
ease was observed in susceptible steers inoculated with 
leukocytes collected from the infected sheep 3–4  days 
after infection. Although BEFV‑neutralising antibodies 
have been reported in sheep and goats in Taiwan [51], 
several other serological studies conducted in BEFV‑
enzootic regions have failed to find evidence of infection 
in sheep [43, 45, 52]. Factors such as low levels of virae‑
mia and the feeding preference of vectors may limit the 
role of sheep in the natural BEFV transmission cycle.
3.2  Vector‑borne transmission
A large body of evidence suggests that BEFV is trans‑
mitted by haematophagous insects. Its geographical 
distribution is mostly in tropical, subtropical and warm 
temperate regions and the pattern of disease is seasonal 
with outbreaks occurring from late spring to autumn [6]. 
It has also been shown that experimental transmission 
of infection requires intravenous injection of infected 
blood and there is no transmission by direct contact with 
infected animals or fomites [53, 54]. Attempts to trans‑
mit BEFV mechanically from various insects were also 
unsuccessful [53]. BEFV has been isolated from several 
potential haematophagous vector species including biting 
midges and mosquitoes. The virus has been isolated from 
Culicoides imicola and C. coarctus in Zimbabwe [55], 
from a mixed pool of biting midges in Kenya, comprising 
C. kingi, C. nivosis, C. bedfordi and C. pallidipennis [29], 
and from C. puncticollis in Turkmenistan [56]. In Aus‑
tralia, there have been isolations from C. brevitarsis [57], 
Anopheles bancroftii mosquitoes and a mixed pool of 
mosquitoes that included Culex, Uranotaenia and Aedes 
spp. [58, 59]. These isolations have been from insects that 
were not recently blood‑engorged.
Attempts to demonstrate vector competence for 
BEFV in mosquitoes and biting midges have met with 
limited success. Artificial membrane‑feeding experi‑
ments showed no evidence of BEFV replication in Aedes 
vigilax but replication to some extent was detected in 
Culex annulirostris 10  days after feeding [60]. In other 
experiments, BEFV was recovered from three of 23 
Cx. annulirostris 12  days after feeding on a blood‑virus 
mixture [59]. It has also been reported that up to 70% 
of Cx. annulirostris inoculated intrathoracically with 
BEFV were found by in vitro capillary tube feeding to be 
excreting virus 7  days after incubation at 26  °C [61]. In 
contrast, BEFV was recovered from only one of 526 C. 
brevitarsis 10 days after feeding on a mixture of sucrose 
and infected mouse brain. In a large study conducted in 
South Africa, biting midges (primarily C. imicola and C. 
bolitinos) collected in the field were fed blood mixed with 
Australian and African strains of BEFV. Although BEFV 
was detected in 18.9% of the midges assayed immedi‑
ately after feeding, none of the >4000 midges surviving at 
10 days post‑feeding were found to be infected [62].
Various other factors also appear to implicate mosqui‑
toes as the principal vectors of BEFV. The observation 
that direct intravenous injection is required to initi‑
ate experimental BEFV infection in cattle suggests that 
capillary feeders (mosquitoes) rather than pool feeders 
(midges) would be required for efficient transmission 
[61]. This is supported by evidence that experimental 
BEFV infection is confined primarily to the blood and 
bone marrow with no evidence of infection in the periph‑
eral lymph system [63]. It has also been observed that 
the geographic distribution of BEFV in Australia extends 
beyond that of the most widely distributed midge species 
(C. brevitarsis) but is similar to the distribution of Cx. 
annulirostris mosquitoes [64]. The epidemiological pat‑
tern in Australia, in which outbreaks commonly follow 
heavy rainfall, also suggests an association with the emer‑
gence of large populations of mosquitoes breeding in 
shallow ground pools [63]. However, the distribution of 
BEFV in Kenya has been reported to extend beyond the 
zones in which mosquitoes are abundant, and its appear‑
ance in locations from which other mosquito‑borne dis‑
eases (such as Rift Valley fever) have not been isolated, 
may suggest transmission by midges [65]. Further work 
is required to better define the vectors of BEFV, includ‑
ing vector competence studies to demonstrate transmis‑
sion following the extrinsic incubation period by vectors 
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fed on infected cattle. It is possible that several species of 
midges and mosquitoes could serve as vectors when sea‑
sonally abundant.
4  History, distribution and epizootiology of BEF
4.1  Global distribution
Bovine ephemeral fever has been described in many trop‑
ical and sub‑tropical regions around the world (Figure 1). 
It is enzootic and seasonally epizootic in Australia, Asia, 
Africa and the Middle East, usually not extending beyond 
a zone limited by the latitudes if 38°N to 36°S [6, 66]. Epi‑
zootics commonly move northwards or southwards in a 
wave‑like fashion, commencing in tropical enzootic foci 
in the spring or early summer and subsiding in autumn 
(Figure 3). Although BEFV is believed to exist as a single 
serotype, phylogenetic studies using G gene ectodomain 
sequences have shown that the available BEFV isolates 
cluster geographically into 3 lineages: East Asia, Australia 
and the Middle East [2, 3, 8, 18, 32] (Figure  4). The G 
gene is a useful genotyping marker as it displays reliable 
alignment with adequate sequence variation to obtain 
precision and resolution, and the absence of genetic 
recombination suggests it is likely to be is representative 
of the entire genome. However, genotype analyses to date 
have been based on limited sampling from most regions 
and there are no sequences available for BEFV isolates 
Figure 3 Likely general directions of seasonal spread of BEFV. A East Asia. B Australia. C Southern Africa. D Middle East. Epizootics appear 
to emerge in the spring or early summer from enzootic foci in tropical regions and extend northwards or southwards through late summer and 
autumn. Pathways shown in East Asia and Australia are based on historical records and recent observations of epizootics, supported by molecular 
epidemiological studies. Pathways in Africa are based only on historical accounts. Pathways in the Middle East are less clear and may be complex 
with potential for epizootics to originate in either East Africa or West Asia. Dashed arrows indicate possible pathways in this region.






















































































































Figure 4 Phylogenetic tree of nucleotide sequences of the G protein ectodomains (1527 nt) of BEFV isolates showing the known 
global genetic diversity of the viruses. The tree was generated from a MUSCLE alignment of the sequences using the maximum likelihood 
method, the GTR + gamma model for nucleotide substitution and SPR branch swapping. Bootstrap analysis was conducted using 100 replicates. 
Genbank accession numbers for all sequences used in the analysis are provided in Additional file 2.
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from Africa or countries in Central, South or South‑East 
Asia.
4.2  Australia
The disease is enzootic in Australia. It was first reported 
in 1936 when an outbreak occurred 450  km south of 
Darwin in the Northern Territory [67]. The remoteness 
of this location suggests that BEFV was likely present 
but undetected prior to the outbreak which occurred 
60 years after the establishment of large cattle holdings 
in the north of the continent. Prior to the late 1970s, BEF 
occurred primarily as large epizootics that swept south‑
wards in a wave‑like fashion out of the northern tropical 
zone into sub‑tropical and warm temperate regions of 
Western Australia, Queensland and New South Wales, 
occasionally reaching northern Victoria. Such epizoot‑
ics occurred in 1936–37, 1955–56, 1967–68, and then 
in succession in 1970–71, 1972–74 and 1974–76 cor‑
responding to periods of unusually high annual rain‑
fall associated with the La Niña phase of the Southern 
Oscillation Index [6, 68–70]. Since that time, the epide‑
miological pattern changed from an advancing north‑
south wave to annual outbreaks during the summer and 
autumn months over a wide area of northern and eastern 
Australia [71]. Regular monitoring of sentinel herds has 
indicated that there are marked differences in seasonal‑
ity between different geographic regions [72]. Sero‑con‑
versions occur perennially in the northern tropical zone 
of the Northern Territory but seasonality increases grad‑
ually with increasing latitude in eastern Australia where 
transmission may cease during the winter months, par‑
ticularly during periods of prolonged drought. BEFV 
sero‑conversions also occur annually in the Kimberley 
region in the far north of Western Australia and are 
detected regularly in the Pilbara region approximately 
1000 km to the south‑west.
Molecular epidemiological studies using G gene ecto‑
domain sequences have shown that all BEFV strains 
isolated in Australia since 1956 have a single common 
ancestor indicating that, unless earlier lineages have 
become extinct, the virus has entered Australia on only a 
single occasion [18]. The phylogenetic data also indicate 
that BEFV is evolving as a single clade across the con‑
tinent at the relatively high evolutionary rate of ~10−3 
nucleotide substitutions/site/year [18]. This suggests that 
most adaptive evolution occurs in the perennial enzootic 
focus in the north where strains are continually selected 
for optimum fitness and regularly move south with the 
onset of summer and autumn rains, displacing the scat‑
tered remnants of enzootic infection. There is also evi‑
dence that the evolution of BEFV in Australia is being 
driven by cross‑reactive neutralising antibody to Kimber‑
ley virus [18] which has a similar geographic distribution 
and ecology to BEFV but has not been associated with 
clinical disease (see below).
4.3  South and South‑East Asia
Although the epidemiology is poorly defined, there is evi‑
dence of BEFV infection in an arc of countries in South 
and South‑East Asia extending from the Indian sub‑con‑
tinent and Sri Lanka, eastwards to the Indonesian Archi‑
pelago and northwards to the Philippines. An ephemeral 
fever resembling BEF was first reported in Pakistan (then 
Punjab) in 1919 as a disease of cattle known locally as 
“Vil” [73]. It was noted that the disease occurred most 
commonly during the rainy season (July to October) and 
simultaneous outbreaks at widely separated locations 
suggested that it was insect‑borne. The disease was also 
reported in Tamil Nadu in the south‑east of India in 1924 
[74]. More recently, BEF has been reported in cattle and 
water buffalo in Uttar Pradesh in the central north [75], 
Gujarat in the west [36] and Himachal Pradesh in the 
far north [76]. In Uttar Pradesh during 1973–1975, BEF 
was reported to occur from April to October with the 
highest incidence in July and August when the weather 
is hot and humid. Disease occurred more frequently in 
Bos taurus/Bos indicus cross‑bred animals than in local 
breeds and the highest incidence occurred in older cat‑
tle [75]. In Nepal, BEF also occurs during the hot, humid 
months of June to October and is considered to be spo‑
radic in some regions and enzootic in others [77]. In Sri 
Lanka, BEF occurs primarily from June to December and 
appears to follow periods of high rainfall [78, 79].
BEF was first reported in Indonesia in 1919 when an 
outbreak occurred in dairy cattle in West Java. The next 
reported epizootic occurred from 1928 to 1931 on the 
east coast of Sumatra [80]. Subsequent outbreaks were 
reported in East Java in 1978, where cases persisted at 
least until 1985 with sometimes quite high mortality 
rates, and in Kalimantan in 1991. A serological survey 
conducted in 1979 detected a high prevalence (78.9%) of 
BEFV‑neutralising antibodies in cattle from Java and Bali 
[81]. Serological surveys conducted between 1987 and 
1990 also detected a relatively high prevalence of BEFV‑
neutralising antibodies in sentinel cattle across much 
of the archipelago including Sumatra, Java, Bali, Timor, 
Kalimantan, Sulawesi and West Papua [80, 82]. Sero‑con‑
versions were seasonal, occurring primarily during the 
wet season from December to June. A BEF epizootic also 
occurred in Papua New Guinea in 1959 but subsequent 
serological surveys in sentinel herds between 1969 and 
1975 failed to detect evidence of infection [68].
Less information is available from other countries in 
the region. A BEF‑like illness was reported in water buf‑
falo in the Philippines in 1936 and passed experimentally 
in water buffalo and cattle, resulting in a brief, non‑fatal 
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febrile illness [83]. BEF was also reported in the Philip‑
pines in 1975–1976 when it affected cattle and water buf‑
falo in 44 provinces in 12 regions, with a case‑fatality rate 
of 5% in water buffalo [84]. There were also local news 
reports in the Philippines of the disease in January 2011. 
A serological survey conducted in southern Thailand in 
1982 revealed BEFV‑specific neutralizing antibodies in 
70% of cattle tested from 11 provinces and 47.5% of water 
buffalo sampled from four provinces [85]. The disease 
has also been reported to occur sporadically in cattle 
and water buffalo in Malaysia, especially following heavy 
rain after period of dry weather [86]. Mortality rates 
were reported to be low but higher in water buffalo than 
in cattle. There are also unconfirmed historical reports 
(1964–1969) of BEF in Laos and Singapore [66].
There have been no confirmed isolations of BEFV from 
South or South‑East Asia and no molecular epidemiolog‑
ical data are available at this time.
4.4  China and East Asia
BEF is enzootic in mainland China [37]. It was first 
reported in Jiangsu Province (north of Shanghai) in 1934 
when the disease was called bovine influenza [87]. Since 
1955, BEF has been recorded in all provinces except Xin‑
jiang and Qinghai in the west, Heilongjiang in the far 
north‑east and the densely populated areas of Tianjin and 
Hebei [87]. In Guangdong Province in the south‑east, out‑
breaks occur almost every year and large epizootics occur 
in the south every 2  years, usually commencing in June 
or July and lasting until November. Approximately every 
4  years, the large epizootics move further northward in 
a wave‑like fashion, affecting provinces such as Henan 
and Anhui in August and September [87]. An outbreak in 
Jilin Province in 1991 remains the most northerly latitude 
(44°N) at which the disease has ever been recorded [88]. A 
serological survey conducted in cattle, water buffalo and 
yak during 2011–2014 detected BEFV‑neutralising anti‑
body in 26 of 28 provinces across the country, including 
Heilongjiang in the far north‑east and Xinjiang in the west 
[37]. Sero‑prevalence varied by location and year with 
highest prevalence (81%) in cattle from Shaanxi Province 
in 2012. Although mortality rates due to BEF in China 
have been typically low (case fatality rates <2%), severe 
disease with case‑fatality rates of 17–18% were reported 
during three epizootics in Henan Province in 2004, 2005 
and 2011 [3]. Phylogenetic analysis based on G gene 
sequences of isolates from the 2011 epizootic showed 
that they clustered with other BEFV isolates from main‑
land China, Taiwan and Japan [3, 18]. The source of this 
strain and the reasons for the high mortality rates is pres‑
ently not known. There have been no similar large epizo‑
otics in Henan since 2011 and case‑fatality rates in other 
provinces have not exceeded 2% (Prof. Hong Yin, Lanzhou 
Veterinary Research Institute, personal communication).
Epizootics also occur periodically in Taiwan, Japan 
and the Korean Peninsula. In Japan, the disease has been 
known since large epizootics, then called bovine influ‑
enza, were recorded in 1889 and 1893 [89]. Similar epizo‑
otics were recorded in 1906–1908, 1929 and 1949–1950 
when the disease was renamed bovine epizootic fever 
and recognised as having the characteristics of BEF [90]. 
There were frequent epizootics in the 1950s and 1960s 
but no major outbreaks have occurred since the intro‑
duction of vaccination in 1973 [91]. Recent outbreaks 
have been sporadic and confined to islands of Okinawa 
Prefecture in the southernmost region of Japan [30, 92]. 
In South Korea, BEFV sero‑conversions were detected 
during 2009–2012 in sentinel cattle from all provinces 
except heavily populated Incheon and Busan [93]. The 
sero‑prevalence and distribution varied from year to 
year with highest prevalence (35.7%) recorded in Daegu 
Province in 2011. It has been shown that BEF epizootics 
in the Korean Peninsula and nearby Fukuoka Prefecture 
in Japan follow a similar pattern [91]. Major epizootics 
occurred simultaneously in 1955, 1958, 1966, 1988 and 
1991 whilst smaller sporadic outbreaks occurred inde‑
pendently in one or other of the countries in other years. 
It has been proposed that low‑level jet stream winds 
allow the displacement of BEFV‑infected vectors across 
the South China Sea and the Sea of Japan [91, 94, 95].
Although the disease called bovine influenza had long 
been known to occur in Taiwan, the first confirmed BEF 
epizootic was in 1967 when an outbreak occurred in the 
Kaoshiung District in the south of the island [96]. Since 
that time, nine epizootics have been reported; those 
occurring in 1983–1984, 1988–1990 and 1996 have been 
described as sweeping epizootics whilst those occur‑
ring in 1999, 2001, 2002, 2004, 2007 and 2012–2013 
were focal or multi‑focal [1, 31, 97, 98]. In most cases 
the first outbreaks were reported in southern Taiwan but 
the 1996 epizootic commenced in central Taiwan and 
the 2002 outbreak commenced in eastern Taiwan. There 
has been a clear trend towards more frequent epizoot‑
ics since 1967 with falling morbidity rates but increasing 
case‑fatality rates. Mortalities due to disease and cull‑
ing exceeded 10% in most epizootics since 1989–1990 
and reached 50% in 2002 [1]. The falling morbidity rate 
has been attributed to the introduction of a vaccine in 
1984. The increased mortality rate has been associated 
with a change in the nature of the disease from an acute 
self‑limiting infection to a more chronic condition in 
which symptomatic treatment with anti‑inflammatory 
drugs and calcium borogluconate are ineffective [97]. 
During the epizootic in 1996, there was evidence that 
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co‑infection with Ibaraki virus (family Reoviridae, genus 
Orbivirus) may have occurred in some cattle, contribut‑
ing to the prolonged nature of the disease and poor prog‑
nosis [96]. A study of 23 BEF outbreaks which occurred 
in Taiwan during the period 2001–2013 suggested a pos‑
sible association between low neutralising antibody titers 
and the occurrence of outbreaks. However, statistical sig‑
nificance for this association was not demonstrated [98].
Phylogenetic analysis using G gene ectodomain 
sequences has shown that isolates from China and East 
Asia collected during the period from 1966 to 2012 form 
a single clade that is distinct from the Australia and Mid‑
dle East clades [3, 18, 30, 31, 98] (Figure  4). There are 
three major sub‑clades within the China/East Asia clade 
comprising isolates that cluster chronologically. The first 
comprises isolates from Taiwan and Japan collected dur‑
ing the 1984 and 1988–89 epizootics; the second com‑
prises isolates from Taiwan, Japan and China collected 
between 1996 and 2012; the third comprises 2011–2012 
isolates from China. A 1976 isolate from China and the 
1966 vaccine strain from Japan are at the deepest ances‑
tral nodes of the China/East Asia clade. The phylogeny 
suggests that BEFV in China/East Asia is evolving largely 
as a single clade and indicates a close epidemiological 
association between viruses circulating across the region.
4.5  Central Asia
There is little published information readily available on the 
occurrence of BEF in Central Asia. Chunikhin and Alek‑
seev [99] referred to the presence of BEFV in the former 
Soviet Union. Sporadic outbreaks have been reported in the 
Amu Darya, Pyandzh and Vahsh Valleys in Tajikistan and 
Uzbekistan, and two BEFV isolates have been reported from 
midges (Culicoides puncticollis) collected in 1980 from cam‑
els in Turkmenistan [56]. There is also a report of a BEFV 
isolate, apparently obtained from Mongolia in 1993, which 
has been used for vaccine production in response to disease 
in territories bordering Russia, including Central Asia and 
Mongolia [100]. A BEF outbreak was also reported in Tajik‑
istan in 2002, affecting the Moskva, Pyandzh and Parkhar 
districts bordering Afghanistan [101]. Epidemiologically, 
this vast region could link the Middle East to China and 
South Asia and so viral sequence data and further informa‑
tion on the status of the disease would be highly valuable.
4.6  Middle East
There are detailed data on the occurrence of BEF in 
Egypt, Israel, Turkey and Saudi Arabia. Serological data 
collected in 2011 has also revealed exposure to BEFV 
in Jordan, primarily in the Jordan Valley (Almajali, per‑
sonal communication). There are also reports of BEF in 
Iran [102, 103] and the disease was recorded in Kuwait, 
Yemen, Iraq and Syria prior to the cessation of formal 
reporting to the OIE in 1970 [66].
In Egypt, BEF was known as “dengue fever” of cattle in 
the late 19th century but the first detailed report was of 
an epizootic in 1909 that commenced at Aswan, travelled 
down the Nile Valley to Cairo and spread across the Delta 
to the coast [104]. Subsequent outbreaks affecting hun‑
dreds of cattle occurred in 1915 and 1919–1920. More 
recently, the disease was reported during the summers 
of 1990–1991, 2000–2001 and 2004–2005 [34, 105]. A 
major epizootic in 1990–1991 affected cattle throughout 
the country, moving along the Nile Valley from Upper 
Egypt in the summer of 1990 to the eastern part of the 
Delta in the autumn [34]. In 1991, the disease affected 
250,000 imported cattle and a smaller number of indig‑
enous cattle and water buffalo all along the Nile Valley, in 
the Delta and at several oases west of the Nile. Morbidity 
rates were reported to vary from 20 to 90% and mortality 
rates in imported cattle were 1.5–3.0%. The source of the 
virus was believed to have been by aerial displacement of 
vectors from regions to the south or the east [34]. Molec‑
ular epidemiological studies of BEFV in Egypt have been 
confined to date to a single report that a virus isolated in 
2005 was very closely related to a 2004 isolate from Tai‑
wan [8]. It was suggested that the virus may have been 
imported through the cattle trade from China to the Mid‑
dle East. However, as this is based on a short sequence of 
the G protein (140 amino acids) that is identical to the 
Taiwanese sequence, the result requires confirmation. A 
full‑length G protein sequence of a 2012 Egyptian BEFV 
isolate which has been deposited in Genbank (KJ729108) 
is most closely related to the 1966 Japanese vaccine strain 
(Figure 4).
BEF was first reported in Israel in 1931 [106]. Until 
1990, it occurred at irregular, long intervals, with the last 
outbreak occurring in 1951 [107]. However, this pattern 
has changed in recent years with increasingly frequent 
outbreaks in 1990–1991, 1999–2001, 2004, 2008, 2009 
and 2010 [8, 107, 108]. The first descriptions of BEF in 
Saudi Arabia and Turkey appeared much later. In Turkey, 
the first reported BEF outbreak occurred in 1985 in the 
central, south and south‑eastern parts of Anatolia, and 
this was followed by outbreaks in 1999, 2003, 2008 and 
2012 [32]. Although most outbreaks occurred in Anatolia 
with predominance in the southern part of the country 
(2, 8, 32), sero‑prevalence of 2.5–15.3% has been reported 
in the western provinces of European Turkey [109]. This 
is the first report of BEF in Europe.
The first unconfirmed outbreaks of BEF in Saudi Arabia 
occurred in 1980 [110]. Subsequent disease outbreaks in 
1990–1991 and 1996 were confirmed serologically [111, 
112] but a survey conducted from 1993 to 1995 revealed 
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no evidence of BEFV antibodies in 910 cattle sampled 
from sentinel herds at six locations across the coun‑
try [113]. Although this indicated that the disease had 
not remained enzootic since the 1990–1991 outbreak, 
another epizootic occurred during 1996, affecting both 
exotic and local breeds in the eastern region of the coun‑
try. The disease was confirmed serologically and by virus 
isolation [114] and it was suggested that the virus may 
have been introduced in arthropod vectors transported 
on prevailing south‑westerly winds from Africa [113]. 
There have been no further reports of outbreaks in Saudi 
Arabia or other countries in the Arabian Peninsula.
BEF outbreaks in the Middle East usually commence 
during the spring (May) or autumn (September) when the 
rains are ceasing and ambient temperatures rise. In Israel, 
the most severe outbreaks usually occur in the Jordan 
Valley were the climate is either Mediterranean or semi‑
arid while in Saudi Arabia, which is mostly arid, the out‑
breaks usually occur at oases in which large populations 
of vectors can emerge [112]. There has been increased 
frequency of epizootics in several countries in the region 
during the past 20 years and several observations suggest 
there may be a connection between the outbreaks which 
have occurred simultaneously in Israel, Egypt and Saudi 
Arabia in 1990, in Turkey, Israel and Egypt in 1999–2000, 
in Egypt and Israel in 2004, and in Turkey and Israel in 
2008. Spread of infection between these sites may have 
occurred either by wind‑borne dispersal of infected vec‑
tors or by transportation of infected cattle. As serological 
surveys conducted between epidemics have indicated the 
absence of infection [8, 113], the intermittent reintroduc‑
tion of the virus from neighboring enzootic countries in 
Asia and Africa appears to be the most likely source of 
epizootics.
4.7  Sub‑Saharan Africa
BEF is enzootic and seasonally epizootic in Africa. The 
first recorded epizootic commenced in north‑western 
Zimbabwe (then Rhodesia) in November 1906. From 
central Zimbabwe, the disease advanced southwards to 
reach Natal and Transvaal by March 1907 and, by the end 
of 1907, it was reported near Port Elizabeth in Eastern 
Cape Province where it remained with intervals of qui‑
escence [50]. Indigenous residents claimed that the dis‑
ease had occurred in Zimbabwe 25 years previously and 
there was a report of a similar disease in native cattle in 
Central Africa dating to approximately 1867 [50, 115]. 
Although transmission by birds associated with locust 
plagues was originally proposed [50], biting midges were 
subsequently implicated by analogy with bluetongue dis‑
ease [115]. Major epizootics were subsequently reported 
in South Africa in 1949, 1953–1955, 1966–68, 1974–74 
and 1981–84 [116]. The epizootic of 1953–1955 was 
particularly severe with mortality rates approaching 30% 
in some herds [117]. BEF is now reported to occur reg‑
ularly in South Africa from the northern border to the 
southern coast. Clinical disease occurs less frequently in 
some districts and the severity and extent of outbreaks 
may vary from year to year. The disease typically appears 
in the late summer, but can occur earlier in the winter 
rainfall region of the Western Cape Province [118]. It has 
also been reported to occur annually in Namibia where it 
occurs later than in South Africa with outbreaks some‑
times extending into the winter [54].
The disease has also been reported to occur in Sudan, 
Kenya, Uganda and Tanzania [66, 119]. BEF was first rec‑
ognised in Kenya in 1913 and reproduced experimentally 
in cattle [65]. It has since occurred at intervals, usually 
associated with years of greater than average rainfall 
when Rift Valley fever was also prevalent, although an 
outbreak was recorded in a region adjacent to saline lakes 
in the absence of recent rain [39, 120]. Epizootics occur 
in all parts of the country and can vary with respect to 
morbidity rates and severity of clinical signs. In inter‑
epizootic periods, seroconversions have been observed in 
cattle and wild ruminants the absence of clinical disease 
[39, 120]. Antibodies to BEFV have also been reported 
in camels from Somalia [47]. BEFV has been isolated 
from cattle and biting midges in Kenya and from cattle in 
Nigeria [26, 29]. In Nigeria, the disease has been known 
to herdsmen for many years, occurring regularly at the 
beginning of the wet season [26].
BEF has also been reported historically to occur spo‑
radically or seasonally in many other African coun‑
tries including Chad, Mauritania, Guinea, Central 
African Republic, Ethiopia, Rwanda, Burundi, Demo‑
cratic Republic of Congo, Zambia, Malawi, Angola, Bot‑
swana, Lesotho, Swaziland and Madagascar [66].
4.8  Wind‑borne dispersal
A significant body of evidence suggests that BEFV disper‑
sal within geographic regions occurs by wind‑borne dis‑
placement of vectors. Spread of BEF in Australia during 
the 1968–1969 epizootic was in accordance with a com‑
bination of monsoonal influence and an intense low pres‑
sure system that developed in inland Queensland [69]. 
This resulted in the wave‑like spread of BEF cases along 
an eventual front of 800 km, moving progressively from 
the Northern Territory to northern Victoria, 3000 km to 
the south. This spread was in the opposite direction to 
the movement of most livestock [70]. In 2008, the rapid 
progression of BEF cases from north‑western New South 
Wales to central and southern parts of the state was pre‑
ceded by the southward movement of a low‑pressure 
system [121]. Both epizootics were preceded by heavy 
rainfall that followed a prolonged drought, stimulating 
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the emergence of large vector populations in the affected 
areas.
Wind‑borne dispersal of vectors has also been impli‑
cated in BEF epizootics in East Asia and the Middle East. 
BEFV incursion into Japan and Korea has been associ‑
ated with the wind direction of a low‑level jet stream from 
China [91, 94] and this is supported by the genetic simi‑
larity between viruses isolated during disease outbreaks 
in each country [30]. A close genetic relationship has also 
been observed for BEFV isolates from an outbreak in Tur‑
key during 2008 and an outbreak in Israel a few months 
later. Forward and backward wind trajectory analysis 
revealed that air parcels originating in a highly affected 
region of southern Turkey reached Israel 9 days prior to 
detection of the index case. As there was no known cat‑
tle trade between Israel and Turkey prior to the outbreak, 
no evidence for serological exposure of cattle and only 
minor exposure of wild animals to BEFV in the inter‑epi‑
demic period (2004–2008), and greater genetic similar‑
ity between the 2008 Israel and Turkish isolates than to 
a virus circulated in Israel during 2000, wind‑borne dis‑
placement of vectors from Turkey was considered to be 
the most likely source of the epizootic strain [8, 43].
4.9  Translocation through the live animal trade
The phylogenetic clustering of BEFV isolates according 
to geographic regions suggests that long distance (inter‑
continental) dispersal of BEFV by animal transport has 
been rare historically. However, several studies have 
shown that recent BEFV isolates from Egypt (2005) and 
Turkey (2012) cluster phylogenetically with isolates from 
the East Asian clade rather than the Middle East clade [8, 
18, 32]. It has been reported that about 5000 cattle were 
exported from China to the Middle East 1 year prior to 
the 2005 outbreak in Egypt. Although no cattle were 
imported from East Asia to Turkey prior to the 2012 out‑
break, transportation may have occurred to neighboring 
countries. It is also possible that the East Asian lineage 
virus in Turkey may have been imported by transporta‑
tion of cattle via Africa. A large outbreak of lumpy skin 
disease, which is usually confined almost exclusively to 
Africa, also occurred in northern Israel and Lebanon 
during 2012 and has been attributed to the legal or illegal 
trade in cattle from Africa to the Middle East. The phylo‑
genetic data certainly suggests that the risk of inter‑conti‑
nental BEFV translocation through the live animal trade 
may be increasing.
5  Other ephemeroviruses
Several other viruses that have been isolated from cattle 
or biting insects are antigenically related to BEFV, some 
of which have been classified as members of the genus 
Ephemerovirus. From a clinical perspective, the most 
significant of these is kotonkan virus (KOTV) which was 
isolated from biting midges (Culicoides spp.) in Nige‑
ria in 1967 [122]. Seroconversion to KOTV neutralising 
antibody has been associated with an ephemeral fever‑
like illness in cattle in Nigeria [122] and mild signs of the 
disease have been observed following experiment infec‑
tion of calves with a mouse brain‑adapted strain of the 
virus [123]. Based primarily on antigenic cross‑reactions 
with Mokola virus in complement‑fixation and indirect 
immunofluorescence tests [24, 122], KOTV was origi‑
nally classified as a lyssavirus but sequence analysis has 
clearly established its classification as a species (Koton-
kan virus) in the genus Ephemerovirus [124]. Other 
established ephemerovirus species include Berrimah 
virus (BRMV), Adelaide River virus (ARV) and Obodhi-
ang virus (OBOV). BRMV was isolated in 1981 from a 
healthy sentinel steer in the Northern Territory of Aus‑
tralia [125]. Antigenically, it is the most closely related 
ephemerovirus to BEFV, cross‑reacting weakly in virus‑
neutralisation tests [124, 125]. Although there is evidence 
of widespread BRMV antibody in cattle in Australia, it 
has never been associated with clinical disease. Neutral‑
ising antibodies to BRMV have also been detected in cat‑
tle in China [87] and in cattle, water buffalo, sheep and 
goats in Indonesia [82]. ARV was also isolated from a 
healthy sentinel steer in the Northern Territory in 1981 
and has no known association with disease [126]. It is 
most closely related antigenically and phylogenetically 
to OBOV which was isolated in 1963 from mosquitoes 
(Mansonia uniformis) in Sudan with which it cross‑reacts 
weakly in virus‑neutralisation tests [124]. Although little 
is known about the ecology or geographic distribution of 
these viruses, antibodies to ARV have also been detected 
in cattle in China and in water buffalo and goats in Indo‑
nesia [82].
Kimberley virus (KIMV), Malakal virus (MALV), 
Koolpinyah virus (KOOLV), Yata virus (YATV) and 
Puchong virus (PUCV) have not yet been classi‑
fied formally but are likely to be assigned to the genus 
Ephemerovirus based on serological and phylogenetic 
relationships, and similarities in genome organisations 
and host/vector associations. KIMV was first isolated 
from mosquitoes (Culex annulirostris) collected in West‑
ern Australia in 1973 [127] and then subsequently on sev‑
eral occasions from biting midges (Culicoides brevitarsis) 
and healthy sentinel cattle in the Northern Territory and 
Queensland [45, 57, 128]. KIMV is indistinguishable in 
virus neutralisation tests from MALV which was iso‑
lated from mosquitoes (Mansonia uniformis) in Sudan 
in 1963, and these are now considered to be variants of 
the same virus species [129]. KIMV antibodies have been 
detected in cattle in China [130] and in cattle, water buf‑
falo, goats and horses in Indonesia [82]. KOOLV was 
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isolated in 1985 and 1986 from healthy sentinel cat‑
tle in the Northern Territory and shown to cross‑react 
in virus‑neutralisation tests with KOTV. At the time of 
the isolations, there was evidence of sero‑conversion to 
KOOLV antibody in other cattle at the same site and in 
sheep infected experimentally with the virus. Subsequent 
sequence analysis of the KOOLV genome has established 
that it is indeed closely related to KOTV with a simi‑
lar genome organisation and high levels of amino acid 
sequence identity between cognate proteins [131]. YATV 
was isolated in 1969 from mosquitoes (Mansonia uni-
formis) collected in the Central African Republic. Recent 
studies have established that YATV clusters phyloge‑
netically with the ephemeroviruses and shares a similar 
genome organization [131]. PUCV was isolated in 1965 
in Malaysia, also from Mansonia uniformis mosquitoes 
and was subsequently shown to cross‑react in comple‑
ment‑fixation tests with MALV (strain SudAr‑1169) and 
in indirect immunofluorescence tests with several other 
ephemeroviruses [24]. Recent sequence analysis has con‑
firmed that PUCV is indeed an ephemerovirus, most 
closely related to KIMV (P.J. Walker and K.R. Blasdell, 
unpublished data). Further studies are required to better 
define the vectors, host range and prevalence, geographic 
distribution and pathogenicity of these poorly character‑
ised ephemeroviruses.
6  Control and treatment of BEF
6.1  Protective immunity
Natural BEFV infection has been reported to result in 
durable immunity [53]. There have been observations of 
multiple episodes of clinical ephemeral fever in the same 
cattle [5, 115, 132] but it is not known if other ephemer‑
oviruses may have been responsible for the disease. A 
strong neutralising antibody response follows natural or 
experimental BEFV infection, developing by the third day 
of clinical disease with titres increasing during recovery 
[133, 134]. It has been reported that specific neutralis‑
ing antibodies last for at least 422  days following natu‑
ral BEFV infection and that previously infected animals 
resist challenge for at least 2 years [135]. There are con‑
flicting reports on the role of neutralising antibodies in 
protection against the disease. Tzipori and Spradbrow 
[136] observed that cattle developing a neutralising anti‑
body response following vaccination with mouse‑brain‑
adapted virus were not consistently resistant to challenge. 
Della‑Porta and Snowdon [137] found no correlation 
between the magnitude of the neutralising antibody 
response to vaccination and protection, and suggested 
that cell‑mediated responses may also be required. 
However, others have observed a correlation between 
BEFV‑specific neutralising antibody titer and protection 
and effective protection has been demonstrated using 
purified preparations of the G protein split from virions 
[16, 31, 138]. Inclusion of N protein in the purified G pro‑
tein vaccine, although stimulating a T‑lymphocyte prolif‑
erative response, did not improve protective efficacy [22]. 
Colostral antibody has also been shown to protect cattle 
against BEFV infection [139] and neutralising G protein 
monoclonal antibodies injected intraperitoneally protect 
suckling mice from paralysis and death [17]. Therefore, it 
appears that the G protein delivered in an appropriately 
folded form and with a suitable adjuvant is sufficient to 
induce protective immunity. A key role for neutralis‑
ing antibodies in protection is also consistent with the 
short incubation period, rapid onset of disease and rapid 
recovery that coincides with the first appearance of neu‑
tralising antibody [133]. However, it is plausible that 
cell‑mediated immunity is also involved in protection, 
particularly for the longer term sequelae that occur in 
some animals.
There is also evidence that innate immunity is involved 
in both the immune response to infection and the pathol‑
ogy of disease. In an elegant experiment, Young and 
Spradbrow [140] challenged calves with BEFV after 
depletion of neutrophils with a specific anti‑bovine 
neutrophil serum of equine origin. Although becoming 
viraemic, the calves did not develop clinical signs and 
no BEFV‑neutralising antibodies were detected. How‑
ever, virus challenge following restoration of neutrophils 
resulted in viraema, clinical signs and a specific neutralis‑
ing antibody response. It appears, therefore, that neutro‑
phils are important in the induction of clinical signs and 
in the development of the humoral immune response. 
This is consistent with evidence that the pathology asso‑
ciated with BEFV infection is primarily due to vascular 
permeability and the cytokine storm resulting from the 
associated inflammatory response [132].
6.2  Vaccines
Four types of BEF vaccine have been developed to date: 
(1) live‑attenuated vaccines; (2) inactivated vaccines; (3) 
sub‑unit G protein‑based vaccines; and (4) recombinant 
vaccines. Live‑attenuated, inactivated and subunit vac‑
cines are being used in the field. Vaccination has been 
adopted to varying extents in Australia, South Africa, 
Namibia, Japan, South Korea, Taiwan, mainland China, 
the Philippines, Turkey, Israel, Kuwait, Oman, Bahrain, 
Saudi Arabia and Egypt. The vaccines differ in the seed 
virus from which they are prepared, the method of atten‑
uation or inactivation, and the adjuvant formulation.
Live‑attenuated vaccines have been prepared by serial 
passage of BEFV in suckling mice and/or in cell cultures, 
including baby hamster kidney (BHK‑21), hamster lung 
(HmLu‑1) or African green monkey kidney (Vero) cells 
[6, 141, 142]. Many of these live‑attenuated vaccines 
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have been administered with aluminium hydroxide or 
Freund’s incomplete adjuvant and require volumes of 
up to 12  mL/dose. A live‑attenuated vaccine employing 
Freund’s incomplete adjuvant has been adopted for com‑
mercial use in South Africa [143]. Vanselow et  al. [138] 
have reported that two 1 mL doses of an attenuated BEF 
vaccine mixed with Quil A (a purified saponin deriva‑
tive) induced higher neutralising antibody titers than 
when using aluminium hydroxide or dextran sulphate 
as adjuvants. The field effectiveness of this vaccine was 
reported to be 90% (2.9% morbidity in vaccinated animals 
as compared to 24.9% in non‑vaccinated cattle) and simi‑
lar effectiveness was observed in a herd naturally infected 
12 months after vaccination [144]. Although it has been 
claimed that Quil A, which is mixed with the vaccine in 
the field shortly before administration, inactivates at least 
99.99% of the virus [138], this effect may be due to aggre‑
gation of virus particles rather than inactivation of infec‑
tivity [6]. The live‑attenuated Quil A vaccine has been 
adopted for commercial use in Australia [144].
Inactivated BEF vaccines have been prepared by treat‑
ment with formalin [142], β‑propriolactone [142, 145], 
binary ethyleneimine [31] or ultraviolet light [142]. Heat‑
inactivation of the virus resulted in failure to induce a 
neutralising antibody response after vaccination [136]. 
Most early inactivated vaccines used either aluminium 
gel or Freund’s incomplete adjuvant [142]. A formalin‑
inactivated, aluminium phosphate gel‑adsorbed vaccine 
developed in Japan was shown to elicit a strong antibody 
response after two doses but immunity waned rapidly 
and neutralising antibody was no longer detected in most 
animals 4 months after vaccination [142]. More recently, 
inactivated vaccines have used water‑in‑oil‑in‑water 
adjuvant [31, 145]. Such a vaccine developed in Israel was 
shown to elicit a stronger and longer lasting neutralising 
antibody response after two vaccinations and showed a 
significant booster effect 9 months after the second vac‑
cination. No safety issues have been reported with this 
vaccine and no effect was observed on milk produc‑
tion in vaccinated cattle [145]. An oil emulsion vaccine 
developed and tested in Taiwan showed 100% protection 
against experimental challenge performed 1 month after 
a single vaccination [31]. The Israeli vaccine showed 50% 
effectiveness in protection from natural challenge after 
three vaccinations but failed to prevent disease when 
administrated only twice [7]. This is consistent with pre‑
vious challenge studies which found that inactivated vac‑
cines elicit protection only after three doses [137].
Inaba et  al. [146] found that consecutive vaccinations 
with live‑attenuated virus followed by inactivated (killed) 
virus resulted in a stronger and more durable neutralis‑
ing antibody response than vaccination with live‑attenu‑
ated vaccine alone or with two doses of the inactivated 
vaccine. No abortions or foetus damage were observed 
and there was no reduction in milk production following 
vaccination with this live‑killed vaccine which has been 
adopted for commercial use in Japan.
In mainland China, effective vaccination has been 
achieved by using the BEFV G protein split from a semi‑
purified virus preparation by using non‑ionic detergent 
[147]. The vaccine, which uses a white oil adjuvant, was 
shown to induce a neutralising antibody response and to 
protect 50% of cattle challenged 6 months after two sub‑
cutaneous doses at an interval of 3 weeks. All cattle with 
neutralising antibody titres >4 were found to be resistant 
to challenge. The vaccine has been adopted for field use 
in China prior to predicted epizootics and, although no 
formal field evaluation has been reported, it appears to 
be safe and effective [147]. A G protein sub‑unit vaccine 
administered in Quil A adjuvant has also been developed 
in Australia [16]. Two doses of the vaccine administered 
on days 0 and 21 or three doses administered on days 0, 
7 and 36 resulted in 100% protection against experimen‑
tal challenge on day 104. It was also shown that three 
doses of 0.32 μg of the purified G protein were required 
for effective protection against challenge at 46 days [16]. 
There has been no field evaluation of this vaccine and it 
has not been adopted commercially.
Vaccination experiments have also been conducted 
using the BEFV G protein delivered in recombinant virus 
vectors. Vaccination with four doses of the Neethling 
strain of lumpy skin disease virus expressing the BEFV G 
protein at 0, 3, 6 and 12 weeks induced a specific neutral‑
ising antibody and cell‑mediated immune responses but 
failed to protect cattle challenged with BEFV 10  weeks 
after the last dose [148]. In the same experiment, a com‑
mercial South African live‑attenuated BEFV vaccine 
induced a stronger neutralisating antibody response but 
provided incomplete protection. Similarly, vaccination of 
cattle at days 0 and 21 with recombinant BEFV G protein 
expressed from the NYBH strain of vaccinia virus has 
been shown to induce specific neutralising antibodies but 
a protection experiment was inconclusive due to the poor 
potency of the challenge virus [13].
In summary, although experimental and commercial 
BEF vaccines have been developed in various formula‑
tions, there are few reports of the evaluation of their 
efficacy in the field. Protective immunity for most of the 
vaccines appears to be of limited duration and so their 
efficacy may be poor unless additional booster doses are 
administered at intervals of 6  months to 1  year. There 
remains a need for further research to provide a more 
informed evaluation of performance in the field and 
to evaluate slow‑release and other advanced technolo‑
gies that may reduce the required number of doses and 
extend the duration of protection.
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6.3  Control of cattle movements
As viraemia is brief (3–5  days) and occurs soon after 
infection, the risks associated with the movement of 
infected cattle pertains mostly to rapid transport across 
relatively short distances and a brief quarantine period 
in a vector‑free area should be sufficient to eliminate the 
risk of introduction of BEFV with imported cattle [149]. 
However, recent phylogenetic evidence that BEFV strains 
of the East Asian lineage appear to be circulating in the 
Middle East [2, 8, 18, 32] suggest that the livestock trade 
has been responsible for the inter‑continental transfer of 
the viruses, either in cattle or in vectors that may have 
accompanied them. Although BEF is not an OIE‑listed 
disease, some countries require that live cattle or bovine 
semen to be imported are tested and shown to be free of 
BEFV‑neutralising antibodies.
6.4  Treatment
BEF is rare amongst viral diseases in that rationally based 
treatment is possible [54]. Rest, protection from the ele‑
ments and the provision of feed and water will assist 
recovery. Laterally recumbent animals should be rolled‑
over several times a day to prevent loss of circulation and 
muscle damage. Force‑feeding is not advisable because 
of the risk of aspiration pneumonia due to an impaired 
swallowing reflex [149]. Non‑steroidal anti‑inflamma‑
tory drugs are effective in preventing the onset of clini‑
cal signs when given daily during the incubation period 
and can induce rapid recovery when given after the onset 
of clinical disease [150]. Clinical signs of hypocalcaemia 
(ruminal stasis, paresis, loss of reflex) can be treated by 
subcutaneous or intravenous injection of calcium boro‑
gluconate. Convalescent animals should not be stressed 
or worked for several days after clinical signs subside to 
ensure biochemical functions have returned to normal 
[54].
7  Conclusions
BEF is a disease for which the economic and social 
impacts are not always obvious and are frequently under‑
estimated. Epizootics are now occurring more frequently 
in some parts of the world, there are increasing reports of 
alarmingly high case‑fatality rates, and there is potential, 
under the influence of climate change and through the 
livestock trade, for spread of the disease to regions that 
are presently free. Although the epizootiology has been 
studied extensively in some regions, little is known of 
the distribution, prevalence and impacts over vast areas 
of Africa and Asia, relatively few virus isolates have been 
recovered and sequenced, and the specific vectors are 
not clearly defined anywhere in the world. This severely 
limits our ability to assess the relative importance and 
risk of spread by wind‑borne dispersal of vectors and 
translocation through movement of livestock, and to 
assess the potential for establishment as an enzootic dis‑
ease in Europe or the Americas through transmission 
by local vectors. Although a multitude of experimental 
and commercial vaccines have been developed, usage 
rates are often poor due to the irregular nature of epizo‑
otics and the need for multiple doses, and there are few 
published reports of the evaluation of vaccines under 
conditions in the field. The role of related viruses in the 
epizootiology of BEF is also unclear. This knowledge defi‑
cit provides a fertile field for future research.
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